PIERANTONI, FRANCESCO

PIERANTONI, FRANCESCO  

Università di Padova  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.055 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 2023 Pierantoni F. + EUROPEAN UROLOGY - -
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience 2023 Pierantoni F.Lai E. + CANCERS - -
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience 2021 Pierantoni F. + JOURNAL OF GERIATRIC ONCOLOGY - -
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations 2023 Pinto A.Ortega C.Pierantoni F. + MINERVA UROLOGY AND NEPHROLOGY - -
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature 2022 Pierantoni F.Lai E. + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience 2022 Lai E.Pierantoni F. + FRONTIERS IN ONCOLOGY - -
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial 2022 Lai E.Pierantoni F. + PATIENT PREFERENCE AND ADHERENCE - -
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a) 2023 Pierantoni F.Prati V. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy 2023 Pierantoni F.Lai E. + FUTURE SCIENCE OA - -
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 2021 Maruzzo M.Del Bianco P.Cavallari I.Pierantoni F.Ciminale V.Zagonel V. + FRONTIERS IN ONCOLOGY - -
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study 2022 Pierantoni F.Bortolami A. + TARGETED ONCOLOGY - -
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 2022 Pierantoni F. + CLINICAL GENITOURINARY CANCER - -
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma 2023 Pierantoni F.Lai E.Lonardi S. + CLINICAL GENITOURINARY CANCER - -